Literature DB >> 26432183

CGRP antibodies: the Holy Grail for migraine prevention?

Julio Pascual1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26432183     DOI： 10.1016/S1474-4422(15)00244-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

1.  New Directions in the Treatment of Chronic Pain: National Pain Strategy Will Guide Prevention, Management, and Research.

Authors:  Susan L Worley
Journal:  P T       Date:  2016-02

2.  CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.

Authors:  Junhui Liu; Guan Wang; Yuan Dan; Xinjie Liu
Journal:  J Headache Pain       Date:  2022-06-13       Impact factor: 8.588

Review 3.  Anti-CGRP monoclonal antibodies in migraine: current perspectives.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Martina Curto; Andrea Negro; Raffaele Costantini; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2016-06-23       Impact factor: 3.397

4.  Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Christodoulos Xinaris; Nefeli Zerva; Konstantinos Filippakis; Angelos Pavlopoulos; Constantinos Pantos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.